Sherif S. Farag
- Immunology top 1%
- Hematology top 0.5%
- Oncology top 2%
- Molecular Biology top 10%
- Genetics top 2%
- Co-authors
- Michael A. CaligiuriTodd A. FehnigerAndrea VelardiLoredana RuggeriRafat AbonourThomas S. LinAttaya SuvannasankhaShuhong Zhang
- Topics
- Hematopoietic Stem Cell Transplantation (41 papers)Multiple Myeloma Research and Treatments (33 papers)Immune Cell Function and Interaction (28 papers)
- Cited by
- HematologyImmunologyGenetics
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Sherif S. Farag
135 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 141
- Immunology 2.0k
- Hematology 1.8k
- Oncology 1.3k
- Molecular Biology 877
- Genetics 594
Countries citing papers authored by Sherif S. Farag
This map shows the geographic impact of Sherif S. Farag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherif S. Farag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherif S. Farag more than expected).
Fields of papers citing papers by Sherif S. Farag
This network shows the impact of papers produced by Sherif S. Farag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherif S. Farag. The network helps show where Sherif S. Farag may publish in the future.
Co-authorship network of co-authors of Sherif S. Farag
This figure shows the co-authorship network connecting the top 25 collaborators of Sherif S. Farag. A scholar is included among the top collaborators of Sherif S. Farag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherif S. Farag. Sherif S. Farag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 0 | |
| 3 | Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis | 2 |
| 4 | 4 | |
| 5 | 22 | |
| 6 | 3 | |
| 7 | 23 | |
| 8 | 19 | |
| 9 | 81 | |
| 10 | The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells | 1 |
| 11 | 17 | |
| 12 | 53 | |
| 13 | 46 | |
| 14 | 35 | |
| 15 | 26 | |
| 16 | 28 | |
| 17 | 9 | |
| 18 | 17 | |
| 19 | 10 | |
| 20 | 13 |
About Sherif S. Farag
Sherif S. Farag is a scholar working on Hematology, Immunology and Transplantation, having authored 137 papers that have together received 4.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (41 papers), Multiple Myeloma Research and Treatments (33 papers) and Immune Cell Function and Interaction (28 papers). The work is most often cited by research in Hematology (1.8k citations), Immunology (2.0k citations) and Genetics (594 citations). Sherif S. Farag has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Michael A. Caligiuri, Todd A. Fehniger, Andrea Velardi, Loredana Ruggeri, Rafat Abonour, Thomas S. Lin, Attaya Suvannasankha, Shuhong Zhang, Hal E. Broxmeyer and Craig C. Hofmeister. Their work appears in journals such as New England Journal of Medicine, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.